Sex-specific differences in fetal and infant growth patterns: a prospective population-based cohort study
- Zoe A. Broere-Brown1Email author,
- Esme Baan1,
- Sarah Schalekamp-Timmermans1,
- Bero O. Verburg^1,
- Vincent W. V. Jaddoe2, 3 and
- Eric A. P. Steegers1
© The Author(s). 2016
Received: 25 August 2016
Accepted: 23 November 2016
Published: 3 December 2016
The objective of this study was to assess whether sex-specific differences in fetal and infant growth exist.
This study was embedded in the Generation R Study, a population-based prospective birth cohort. In total, 8556 live singleton births were included. Fetal growth was assessed by ultrasound. During the first trimester, crown-rump-length (CRL) was measured. In the second and third trimester of pregnancy head circumference (HC), abdominal circumference (AC) and femur length (FL) were assessed. Information on infant growth during the first 2 years of life was obtained from Community Health Centers and included HC, body weight and length.
In the first trimester, male CRL was larger than female CRL (0.12 SD [95% CI 0.03,0.22]). From the second trimester onwards, HC and AC were larger in males than in females (0.30 SD [95% CI 0.26,0.34] and 0.09 SD [95% CI 0.05,0.014], respectively). However, FL in males was smaller compared to female fetuses (0.21 SD [95% CI 0.17,0.26]). Repeated measurement analyses showed a different prenatal as well as postnatal HC growth pattern between males and females. A different pattern in body weight was observed with a higher body weight in males until the age of 12 months where after females have a higher body weight.
Sex affects both fetal as well as infant growth. Besides body size, also body proportions differ between males and females with different growth patterns. This sexual dimorphism might arise from differences in fetal programming with sex specific health differences as a consequence in later life.
KeywordsFetal sex Fetal growth Growth pattern Biometric indices
Embryonic and fetal growth are dependent on many factors including adequate placental development and function. This can be reflected by several placental biomarkers in maternal plasma such as the pro-angiogenic placental growth factor (PlGF) and the anti-angiogenic soluble fms-like tyrosine kinase 1 (s-Flt1) [1, 2]. Previous studies have shown associations between placental biomarkers and fetal growth [3–5].
Recently, fetal sex-specific differences in placental biomarkers were observed with higher first trimester levels of s-Flt1 and PlGF in women carrying a female fetus. This may suggest that placentation processes differ according to fetal sex [6, 7]. This difference in placental function might influence fetal growth and/or fetal programming in a sex-specific manner. Indeed, previous research has shown fetal sex-specific differences in biometrical indices and growth patterns, and fetal sex-specific growth curves were created . However, these growth curves were based on cross-sectional data and serial measurements of the same fetus were not available. Moreover, it is of interest to investigate whether sex-specific differences in fetal growth persist into infancy since the Development and Origins of Health and Disease (DOHaD) theory states that deviations in early growth are associated with adverse health in later life.
With this study, we investigate whether there are fetal sex-specific differences in fetal and infant growth in a large study population. We repeatedly assessed fetal growth during pregnancy by measuring crown-rump-length (CRL) in the first trimester, and several biometrical indices (head circumference (HC), abdominal circumference (AC) and femur length (FL)) in the second and third trimester of pregnancy. After pregnancy until the age of 2 years, growth was assessed at several time points by assessing HC and body weight and length. In addition, we explore the effect of the presence or absence of the placental syndrome on these differences.
Precise initial dating by early ultrasonography is vital to ensure accurate pregnancy dating, especially when assessing fetal growth. Dating of pregnancy was performed using the first ultrasound measurement of either the CRL (if the gestational age was below 12 weeks and 5 days and CRL measurement <65 mm), or the biparietal diameter (BPD) (from a gestational age from 12 weeks and 5 days onwards with a BPD >23 mm). Establishing gestational age with fetal ultrasound examinations is the most accurate method for pregnancy dating [10–12].
Since pregnancy dating was based on CRL, only CRL measurements of women with a known and reliable first day of the last menstrual period (LMP) with a regular cycle (lasting 28 days +/- 4 days) were included in the analyses (n = 1782). For the purpose of analyses on CRL measurement, pregnancy dating in this subgroup of women was not based on CRL but on the LMP.
Second and third trimester
Fetal ultrasound examinations were performed in the second (median 20.5 weeks of gestation, 90% range 18.9–22.9) and third trimester (median 30.3 weeks of gestation, 90% range 28.7–32.4). Fetal biometry (HC, AC, and FL) was performed trans abdominally during each ultrasound examination. Standardized ultrasound planes for HC, AC, and FL are described elsewhere [13–15]. Estimated fetal weight (EFW) was calculated using the formula of Hadlock with parameters AC, HC, and FL (in cm): EFW = 10**(1.326 −0.00326*AC*FL + 0.0107*HC + 0.0438*AC + 0.158*FL .
Gestational age-adjusted standard deviation scores (SDS) were calculated for all fetal growth measurements, including CRL measurements. These gestational age-adjusted standard deviation scores were based on reference growth curves from the whole study population and represent the equivalent of Z-scores . Ultrasound examinations were performed using an Aloka® model SSD-1700 (Tokyo, Japan) or the ATL-Philips® Model HDI 5000 (Seattle, WA, USA).
Delivery and birth complications
Information on gestational age at birth, offspring sex, and pregnancy complications (pre-eclampsia [PE], a neonate born small for gestational age [SGA] and/or spontaneous preterm birth [sPTB]) was obtained from medical records. sPTB was defined as a spontaneous onset of birth <37 weeks of gestation. SGA was defined as a gestational age and fetal sex-adjusted birthweight below the 10th percentile . Pre-eclampsia was defined as the development of SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg after 20 weeks of gestation plus the presence of proteinuria (≥0.3 g in a 24-hour urine specimen or ≥2 + [1 g/L] on a voided specimen, or ≥1 + [0.3 g/L] on a catheterized specimen) in previously normotensive women .
Well-trained staff in the Community Health Centers obtained postnatal growth characteristics according to standard schedules and procedures at the median ages of 1.1 (90% range 0.8–1.6), 2.2 (90% range 2.0–2.9), 3.3 (90% range 3.0–3.9), 4.4 (90% range 4.0–4.9), 6.2 (90% range 5.4–7.6), 11.1 (90% range 10.2–12.3), 14.3 (90% range 13.7–15.7), 18.3 (90% range 17.5–20.8) and 24.8 (90% range 23.6–27.5) months. Growth characteristics included body weight, length, and HC. SD scores were obtained with the Dutch growth reference charts (Growth Analyzer 3.0, Dutch Growth Research Foundation, Rotterdam, The Netherlands).
Firstly, we performed student t tests and Chi-square tests to test sex-specific differences in fetal growth characteristics. Linear regression analyses were then performed to relate fetal biometric indices to sex. To further explore growth patterns between female and male fetuses and infants, repeated measurement regression models were performed using the mixed model procedure with fetal and infant growth as a repeated outcome measure. These models take the correlation between repeated measurements of the same subject into account. Regarding the repeated measurement analyses that we used to assess fetal growth patterns, we used SDS according to the Niklasson growth standards. This standard adjusts for fetal sex. In addition, we stratified for fetal sex in our analyses, which creates the potential risk of overadjusting. The growth standard of Usher and McLean is to our knowledge the only standard available not adjusting for fetal sex . Repeated measurement analyses on weight using this standard instead of the Niklasson standard are shown in Additional file 1: Figure S1. Finally, to investigate differences in fetal growth in pregnancies with a suboptimal intrauterine environment, we created the composite outcome scores “complicated pregnancy” and “uncomplicated pregnancy”. Pregnancies complicated by either PE and/or sPTB and/or SGA were classified as being complicated. Uncomplicated pregnancies were defined by the absence of all these complications. All abovementioned linear regression and repeated measurement analyses were also performed within strata of these composite scores. Since fetal sex does not have any true confounding factors (e.g., smoking, folic acid intake, maternal ethnicity), primary analyses were not adjusted for any covariates. However, since including these covariates into the analyses may be informative, we included them in additional analyses shown in Additional file 2: Table S1. By using SD scores of all outcomes, we automatically adjusted for gestational age at the time of measurement.
Lastly, effect modification was tested on a multiplicative scale with maternal smoking and ethnicity. If the interaction term was statistically significant, regression or repeated measurement analyses were performed in strata of that specific determinant.
Statistical analyses were performed using either the Statistical Package of Social Sciences version 21.0 for Windows (SPSS Inc., Chicago, IL, USA) or the Statistical Analysis System version 9.3 (SAS, Institute Inc., Gary NC, USA).
Baseline characteristics stratified by fetal sex
n = 8556
n = 4230
n = 4326
Folic acid use-yes (%)
Before 10 weeks
Gestational age at sonography (wks)
Gestational age at birth (wks)
Effect of sex on fetal growth
Already in the first trimester, fetal growth differed between the two sexes. Male fetuses had a larger CRL as compared to female fetuses with a difference of 0.12 SD [95% CI 0.03,0.22, p < 0.001]. In the second trimester of pregnancy, male fetuses had a lower EFW of 0.05 SD [95% CI 0.00,0.09, p = 0.03] calculated with the Hadlock formula. In the third trimester, no differences concerning EFW were observed. At birth, male neonates were on average of 188 g heavier than female neonates [95% CI 182,193, p < 0.001].
Linear regression analyses on fetal growth
0.09 [0.05, 0.14]***
0.30 [0.26, 0.34]***
−0.21 [−0.26, −0.17]***
0.38 [0.34, 0.42]***
−0.21 [−0.26, −0.17]***
0.10 [0.05, 0.15]***
0.29 [0.25, 0.34]***
−0.21 [−0.25, −0.16]***
0.12 [0.07, 0.16]***
0.38 [0.34, 0.43]***
−0.20 [−0.25, −0.15]***
0.09 [−0.03, 0.21]
0.38 [0.26, 0.50]***
−0.26 [−0.38, −0.13]***
0.04 [−0.08, 0.17]
0.42 [0.30, 0.54]***
−0.27 [−0.40, −0.15]***
Regarding analyses assessing the effects of a suboptimal intrauterine environment, i.e., complicated versus uncomplicated pregnancies, similar trends were observed with larger AC and HC and smaller FL in male fetuses compared to female fetuses (all p < 0.001). The only exception is that the AC in the complicated group did not differ between male and female fetuses in both the second and third trimester of pregnancy (respectively p = 0.11 and p = 0.46).
Effect of fetal sex on infant growth
We did not find an interaction with maternal smoking or ethnicity on both fetal and infant growth characteristics.
In this study, we demonstrate fetal sex-specific differences in fetal growth. These differences are already present from the first trimester of pregnancy onwards and track throughout pregnancy. Male and female fetuses do not only differ in weight but also differ in biometric indices with a different body proportion as a consequence. Moreover, male fetuses follow a different growth pattern than female fetuses with a slower growth rate of the HC. The presence of PE, SGA, or PTB does not affect this. During infancy, the difference in HC growth patterns persists and a difference in weight patterns arises.
The Development and Origins of Health and Disease (DOHaD) theory states that in the case of adverse fetal exposure, the unborn fetus can modify its own development such that it will be prepared for survival in an environment in which resources are likely to be short. These early life adaptations help in survival by selecting an appropriate trajectory of growth in response to the environment. Although these adaptations may be beneficial for short-term survival, they may have adverse consequences at birth or in later life [20, 21]. The sex-specific differences in body proportion and fetal growth shown in this study might therefore be one of the bases for sex differences shown in chronic diseases in later life. Especially, since this study shows that sexual dimorphism in growth persist after birth until the age of two years. Little research has been done on differences in growth patterns between males and females. Some studies performed on a later age acknowledge differences in body proportions . Moreover, peak velocity in growth differs between males and females since the timing of the beginning of puberty and therefore growth spurt is different [23, 24]. This is one of the first studies showing that differences in growth patterns between males and females begin at a very early age.
Fetal sex-specific differences in fetal growth and growth patterns may be explained by differences in placentation as previously suggested by our group . Maternal serum levels of s-Flt1, PLGF, and PAI-2 were shown to be higher in the presence of a female fetus. However, Bouwland-Both et al. from our group showed positive associations between maternal s-Flt1, PLGF, plasminogen activator inhibitor 2 (PAI-2) in early pregnancy and CRL . According to these results, one would expect that female CRL is increased compared with male CRL. However, this study showed that male embryos had a larger CRL as compared with females. Considering the effect of placental biomarkers on embryonic growth and the sex-specific differences in these biomarkers, this conflicting result might be explained by effect modification. Hence, the effect of placental biomarkers on CRL is dependent on fetal sex. For this reason, we performed additional interaction analyses showing that in a male embryo, PAI-2 has a larger effect on CRL SDS than in a female embryo (data not shown). Furthermore, we added our data on placental biomarkers (the first and second trimester s-Flt1 and PLGF) into the statistical models to test possible mediating effects of these biomarkers as a proxy for placentation (Additional file 2: Table S1). Although results remained significant, several effect estimates changed with more than 10%. This implies an intermediate role for placental biomarkers. Moreover, extra-placental sources of these biomarkers exist. Previous studies show that s-Flt1 is also produced by maternal endothelial cells . These extra-placental sources could potentially contribute to the differences in early embryonic growth since these biomarkers are associated with CRL.
Some studies state that fetal growth is the result of the availability of nutrients and therefore is mainly determined by placental function . However, until the 11th week of pregnancy, cytotrophoblast plugs obliterate the tips of the utero-placental arteries preventing blood flow with the consequence that fetal growth is not dependent on hemotrophic nutrition during the first trimester. Hence, it is plausible that in early pregnancy, not only placentation determines fetal growth but also other underlying factors such as intrinsic factors of the fetus (i.e., sex). We observed no differences between male and female fetal growth patterns in complicated and uncomplicated pregnancies. This may indicate that physiological placental regulatory mechanisms may be overruled by the pathophysiological sequelae in pregnancies complicated by PE, SGA, and PTB [6, 27].
Concerning biometrical indices, little research has been performed focusing on fetal sex. One study reported on sex-specific antenatal growth charts . However, these growth charts were based on a population of 4234 women with just one antenatal measurement. Similar with our present study, they showed larger HC and AC in male fetuses. In contrast with our results, they showed that the difference between male and female HC increased with proceeding gestation. They did not show an effect of fetal sex on FL. Another study also assessed fetal sex-specific differences in biometrical indices . They too found a larger HC in the case of a male fetus. This study had a smaller sample size of 427 measurements, and analyses were performed cross-sectional.
In our study, we observed a discrepancy in EFW and birthweight. Birthweight was higher in males, while EFW in the second and third trimester of pregnancy was higher in females. This inconsistency can either be explained by the applied formula estimating EFW or by the method used to determine gestational age of pregnancy. The Hadlock formula uses HC, AC, and FL to calculate the EFW. In our study, male and female fetuses differed in body composition with different indices for male and female fetuses. The Hadlock formula could therefore be improved by adjusting for fetal sex as previously suggested by others [8, 30–33]. Melamed et al. constructed a fetal sex-adjusted Hadlock formula which indeed showed a decrease in the systematic error . Secondly, to determine gestational age of pregnancy, we used either the first trimester CRL or BPD measurement. This study however shows that CRL of a male embryo is larger than that of a female embryo. A possible consequence is that male embryos were dated as being older which might explain why females have a higher EFW during the second and third trimester. Lastly, we have to consider the possibility that the growth rate of female fetuses is relatively high in the second trimester while the growth rate of males is higher in the third trimester. This is confirmed by de Jong et al. who showed that the daily growth rate in the third trimester prior to birth was significantly higher for male fetuses . This would indeed result in a higher EFW in the second trimester but a lower birthweight for female fetuses as seen in this study.
In conclusion, we can state that there are differences in fetal and infant growth between males and females. These findings help us in the understanding of the mechanism of growth which is not only important for birth outcome but also predisposes for possible adverse adult health. In clinical practice as well as future research concerning placentation and fetal development and growth, sex has to be taken into account.
The Generation R Study is being conducted by the Erasmus Medical Center in close collaboration with the School of Law and the Faculty of Social Sciences of the Erasmus University, Rotterdam; the Municipal Health Service, Rotterdam area; the Rotterdam Homecare Foundation; and the Stichting Trombosedienst and Artsenlaboratorium Rijnmond, Rotterdam, The Netherlands. We gratefully acknowledge the contributions of the general practitioners, hospitals, midwives, and the pharmacies in Rotterdam.
The Generation R Study was made possible with the financial support from the Erasmus Medical Center, Erasmus University Rotterdam, the Netherlands Organisation for Health Research and Development, the Netherlands Organisation for Scientific Research, the Ministry of Health, Welfare and Sport, and the Ministry for Youth and Families. Prof. Vincent Jaddoe received additional grants from the Netherlands Organisation for Health Research and Development (grant nos. 90700303 and 916.10159).
Availability of data and materials
The datasets analyzed during the current study are available from the corresponding author on reasonable request.
ZB analyzed the data and wrote the article. EB assisted with the analyses and writing of the article. SS contributed to the design of the article and assisted with the analyses and writing of the article. BV contributed to the design of the study, interpretation of the data, revisions, and gave input at all stages of the study. VJ contributed to the design of the study, interpretation of the data, revisions, and gave input at all stages of the study. ES contributed to the design of the study, writing of the article, interpretation of the data, revisions, and gave input at all stages of the study. All authors have approved the final version of the manuscript.
Author Bero Verburg sadly passed away 25 May 2015 at the age of only 42 years. He was internationally recognized for his work on the Generation R Study. This manuscript has been amongst his final work, and he was proud to have been working on it.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from all participants.
Ethics approval and consent to participate
The study was approved by the Medical Ethics Committee of the Erasmus Medical Centre, Rotterdam, The Netherlands (MEC 198.782/2001/31). Written informed consent was obtained from all participants.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Makrydimas G, Sotiriadis A, Savvidou MD, Spencer K, Nicolaides KH. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy. Prenat Diagn. 2008;28(3):175–9.View ArticlePubMedGoogle Scholar
- Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998;59(6):1540–8.View ArticlePubMedGoogle Scholar
- Bouwland-Both MI, Steegers EA, Lindemans J, Russcher H, Hofman A, Geurts-Moespot AJ, et al. Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: the Generation R study. Am J Obstet Gynecol. 2013;209(2):121 e1–11.View ArticleGoogle Scholar
- Staff AC, Harsem NK, Braekke K, Hyer M, Hoover RN, Troisi R. Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies. Eur J Obstet Gynecol Reprod Biol. 2009;143(1):29–33.View ArticlePubMedGoogle Scholar
- Sundrani D, Khot V, Pisal H, Mehendale S, Wagh G, Joshi A, et al. Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy. PLoS ONE. 2013;8(1):e54153.View ArticlePubMedPubMed CentralGoogle Scholar
- Brown ZA, Schalekamp-Timmermans S, Tiemeier HW, Hofman A, Jaddoe VW, Steegers EA. Fetal sex specific differences in human placentation: a prospective cohort study. Placenta. 2014;35(6):359–64.View ArticlePubMedGoogle Scholar
- Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome? Gend Med. 2007;4(1):19–30.View ArticlePubMedGoogle Scholar
- Melamed N, Meizner I, Mashiach R, Wiznitzer A, Glezerman M, Yogev Y. Fetal sex and intrauterine growth patterns. J Ultrasound Med. 2013;32(1):35–43.PubMedGoogle Scholar
- Jaddoe VW, van Duijn CM, Franco OH, van der Heijden AJ, van Iizendoorn MH, de Jongste JC, et al. The Generation R Study: design and cohort update 2012. Eur J Epidemiol. 2012;27(9):739–56.View ArticlePubMedGoogle Scholar
- Campbell S, Warsof SL, Little D, Cooper DJ. Routine ultrasound screening for the prediction of gestational age. Obstet Gynecol. 1985;65(5):613–20.PubMedGoogle Scholar
- Olesen AW, Thomsen SG. Prediction of delivery date by sonography in the first and second trimesters. Ultrasound Obstet Gynecol. 2006;28(3):292–7.View ArticlePubMedGoogle Scholar
- Tunon K, Eik-Nes SH, Grottum P. A comparison between ultrasound and a reliable last menstrual period as predictors of the day of delivery in 15,000 examinations. Ultrasound Obstet Gynecol. 1996;8(3):178–85.View ArticlePubMedGoogle Scholar
- Hadlock FP, Deter RL, Harrist RB, Park SK. Fetal abdominal circumference as a predictor of menstrual age. AJR Am J Roentgenol. 1982;139(2):367–70.View ArticlePubMedGoogle Scholar
- Hadlock FP, Harrist RB, Deter RL, Park SK. Fetal femur length as a predictor of menstrual age: sonographically measured. AJR Am J Roentgenol. 1982;138(5):875–8.View ArticlePubMedGoogle Scholar
- Shepard M, Filly RA. A standardized plane for biparietal diameter measurement. J Ultrasound Med. 1982;1(4):145–50.PubMedGoogle Scholar
- Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. Am J Obstet Gynecol. 1985;151(3):333–7.View ArticlePubMedGoogle Scholar
- Verburg BO, Steegers EA, De Ridder M, Snijders RJ, Smith E, Hofman A, et al. New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol. 2008;31(4):388–96.View ArticlePubMedGoogle Scholar
- Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IX–XIV.View ArticlePubMedGoogle Scholar
- Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr. 1969;74(6):901–10.View ArticlePubMedGoogle Scholar
- Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;1(8489):1077–81.View ArticlePubMedGoogle Scholar
- Pollack RN, Divon MY. Intrauterine growth retardation: definition, classification, and etiology. Clin Obstet Gynecol. 1992;35(1):99–107.View ArticlePubMedGoogle Scholar
- Nowak-Szczepanska N, Koziel S. Sexual dimorphism in growth in the relative length of the forearm and relative knee height during adolescence. Am J Phys Anthropol. 2016;161(2):276-82.
- Grumbach MM. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J Pediatr Endocrinol Metab. 2000;13 Suppl 6:1439–55.PubMedGoogle Scholar
- Juul A. The effects of oestrogens on linear bone growth. Hum Reprod Update. 2001;7(3):303–13.View ArticlePubMedGoogle Scholar
- Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, Weich HA. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest. 2000;80(4):443–54.View ArticlePubMedGoogle Scholar
- Bauer MK, Harding JE, Bassett NS, Breier BH, Oliver MH, Gallaher BH, et al. Fetal growth and placental function. Mol Cell Endocrinol. 1998;140(1-2):115–20.View ArticlePubMedGoogle Scholar
- Burton GJ, Jauniaux E, Watson AL. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol. 1999;181(3):718–24.View ArticlePubMedGoogle Scholar
- Schwarzler P, Bland JM, Holden D, Campbell S, Ville Y. Sex-specific antenatal reference growth charts for uncomplicated singleton pregnancies at 15–40 weeks of gestation. Ultrasound Obstet Gynecol. 2004;23(1):23–9.View ArticlePubMedGoogle Scholar
- L’Ubusky M, Mickova I, Prochazka M, Dzvincuk P, Mala K, Cizek L, et al. [Discrepancy of ultrasound biometric parameters of the head (HC—head circumference, BPD—biparietal diameter) and femur length in relation to sex of the fetus and duration of pregnancy] Diskrepance ultrazvukovych biometrickych parametru hlavicky (HC—head circumference, BPD—biparietal diameter) a delky stehenni kosti (FL—femur lenght) v zavislosti na pohlavi plodu a delce tehotenstvi. Ceska Gynekol. 2006;71(3):169–72.PubMedGoogle Scholar
- Barel O, Maymon R, Barak U, Smorgick N, Tovbin J, Vaknin Z. A search for the most accurate formula for sonographic weight estimation by fetal sex—a retrospective cohort study. Prenat Diagn. 2014;34(13):1337–44.View ArticlePubMedGoogle Scholar
- Melamed N, Ben-Haroush A, Meizner I, Mashiach R, Glezerman M, Yogev Y. Accuracy of sonographic weight estimation as a function of fetal sex. Ultrasound Obstet Gynecol. 2011;38(1):67–73.View ArticlePubMedGoogle Scholar
- Schild RL, Sachs C, Fimmers R, Gembruch U, Hansmann M. Sex-specific fetal weight prediction by ultrasound. Ultrasound Obstet Gynecol. 2004;23(1):30–5.View ArticlePubMedGoogle Scholar
- Trudell AS, Cahill AG, Tuuli MG, MacOnes GA, Odibo AO. Stillbirth and the small fetus: use of a sex-specific versus a non-sex-specific growth standard. J Perinatol. 2015;35(8):566–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Melamed N, Yogev Y, Ben-Haroush A, Meizner I, Mashiach R, Glezerman M. Does use of a sex-specific model improve the accuracy of sonographic weight estimation? Ultrasound Obstet Gynecol. 2012;39(5):549–57.View ArticlePubMedGoogle Scholar
- De Jong CLD, Gardosi J, Baldwin C, Francis A, Dekker GA, Van Geijn HP. Fetal weight gain in a serially scanned high-risk population. Ultrasound Obstet Gynecol. 1998;11(1):39–43.View ArticlePubMedGoogle Scholar